Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Barcos

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Leukemia Research|May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literatureOmar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
Cancer|March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
Cancer|October 30, 2013
Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemiaHun Ju Lee, Josephia R Muindi, Wei Tan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.
Leukemia & Lymphoma|May 30, 2009
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trialAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Leukemia Research|May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literatureOmar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group BBruce A Peterson, Gina R Petroni, Glauco Frizzera, et al.
Cancer|March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
Cancer|October 30, 2013
Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemiaHun Ju Lee, Josephia R Muindi, Wei Tan, et al.
Pageof 3